Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
Jennifer N. Brudno, Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John M. Rossi, Allen Xue, Adrian Bot, Nathalie Scholler, Lekha Mikkilineni, Mark Roschewski, Robert M. Dean, Raúl E. Cachau, Philippe Youkharibache, Rashmika Patel, Brenna Hansen, David F. Stroncek, Steven A. Rosenberg, Ronald E. Gress, James N. Kochenderfer
Topics & Concepts
LymphomaMedicineCD19Chimeric antigen receptorImmunogenicityImmunologyToxicityDiffuse large B-cell lymphomaT cellAntigenInternal medicineImmune systemCAR-T cell therapy researchIntegrated Circuits and Semiconductor Failure AnalysisSilicon Carbide Semiconductor Technologies